Key result
Pulsed field ablation treats atrial and ventricular arrhythmias using non-thermal energy to limit collateral damage.
Why the study?
Pulsed field ablation is a novel non-thermal energy modality with limited collateral damage to surrounding structures, warranting a comprehensive review of its mechanisms, safety, efficacy, and clinical applications.
This review summarizes the mechanisms, safety, efficacy, and clinical applications of pulsed field ablation for managing atrial and ventricular arrhythmias.
May reduce collateral injury during arrhythmia ablation; leaves open need for randomized trials to guide adoption.
One of the recent advancements in the field of cardiac electrophysiology is pulsed field ablation (PFA). PFA is a novel energy modality that does not rely on thermal processes to achieve ablation which, in turn, results in limited collateral damage to surrounding structures. In this review, we discuss the mechanisms, safety, efficacy, and clinical applications of PFA for the management of atrial and ventricular arrhythmias. We also summarize the published pre-clinical and clinical studies regarding this new technology.
No takes yet. Share an insight, caveat, or question.
Ezzeddine et al. (2024) conducted a review in Atrial and ventricular arrhythmias. Pulsed field ablation (PFA) was evaluated. Pulsed field ablation is a novel non-thermal energy modality for the management of atrial and ventricular arrhythmias that limits collateral damage to surrounding structures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: